NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL DN |
634 |
384 |
All SZGR 2.0 genes in this pathway |
KIM RESPONSE TO TSA AND DECITABINE UP |
129 |
73 |
All SZGR 2.0 genes in this pathway |
SENGUPTA NASOPHARYNGEAL CARCINOMA DN |
349 |
157 |
All SZGR 2.0 genes in this pathway |
IGARASHI ATF4 TARGETS DN |
90 |
65 |
All SZGR 2.0 genes in this pathway |
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 DN |
175 |
82 |
All SZGR 2.0 genes in this pathway |
TURASHVILI BREAST CARCINOMA DUCTAL VS LOBULAR UP |
21 |
14 |
All SZGR 2.0 genes in this pathway |
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP |
177 |
110 |
All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL UP |
450 |
256 |
All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER BASAL VS MESENCHYMAL UP |
121 |
45 |
All SZGR 2.0 genes in this pathway |
DOANE RESPONSE TO ANDROGEN UP |
184 |
125 |
All SZGR 2.0 genes in this pathway |
ROY WOUND BLOOD VESSEL DN |
22 |
14 |
All SZGR 2.0 genes in this pathway |
GAL LEUKEMIC STEM CELL DN |
244 |
153 |
All SZGR 2.0 genes in this pathway |
VECCHI GASTRIC CANCER ADVANCED VS EARLY DN |
138 |
70 |
All SZGR 2.0 genes in this pathway |
JAEGER METASTASIS DN |
258 |
141 |
All SZGR 2.0 genes in this pathway |
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN |
275 |
168 |
All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D DN |
205 |
127 |
All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN |
142 |
90 |
All SZGR 2.0 genes in this pathway |
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN |
143 |
83 |
All SZGR 2.0 genes in this pathway |
TIEN INTESTINE PROBIOTICS 24HR DN |
214 |
133 |
All SZGR 2.0 genes in this pathway |
SABATES COLORECTAL ADENOMA UP |
141 |
75 |
All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA UP |
1821 |
933 |
All SZGR 2.0 genes in this pathway |
HAHTOLA SEZARY SYNDROM UP |
98 |
58 |
All SZGR 2.0 genes in this pathway |
HAHTOLA MYCOSIS FUNGOIDES UP |
19 |
15 |
All SZGR 2.0 genes in this pathway |
ENK UV RESPONSE EPIDERMIS UP |
293 |
179 |
All SZGR 2.0 genes in this pathway |
MISSIAGLIA REGULATED BY METHYLATION UP |
126 |
78 |
All SZGR 2.0 genes in this pathway |
WANG BARRETTS ESOPHAGUS UP |
51 |
27 |
All SZGR 2.0 genes in this pathway |
MUELLER METHYLATED IN GLIOBLASTOMA |
40 |
22 |
All SZGR 2.0 genes in this pathway |
LI AMPLIFIED IN LUNG CANCER |
178 |
108 |
All SZGR 2.0 genes in this pathway |
PATIL LIVER CANCER |
747 |
453 |
All SZGR 2.0 genes in this pathway |
KANG GIST WITH PDGFRA DN |
5 |
5 |
All SZGR 2.0 genes in this pathway |
TSUNODA CISPLATIN RESISTANCE DN |
51 |
38 |
All SZGR 2.0 genes in this pathway |
WOOD EBV EBNA1 TARGETS DN |
47 |
33 |
All SZGR 2.0 genes in this pathway |
MOHANKUMAR TLX1 TARGETS DN |
193 |
112 |
All SZGR 2.0 genes in this pathway |
WANG HCP PROSTATE CANCER |
111 |
69 |
All SZGR 2.0 genes in this pathway |
GRUETZMANN PANCREATIC CANCER UP |
358 |
245 |
All SZGR 2.0 genes in this pathway |
NUYTTEN NIPP1 TARGETS DN |
848 |
527 |
All SZGR 2.0 genes in this pathway |
WU CELL MIGRATION |
184 |
114 |
All SZGR 2.0 genes in this pathway |
AMIT SERUM RESPONSE 480 MCF10A |
39 |
20 |
All SZGR 2.0 genes in this pathway |
LIN SILENCED BY TUMOR MICROENVIRONMENT |
108 |
73 |
All SZGR 2.0 genes in this pathway |
ONDER CDH1 TARGETS 2 DN |
464 |
276 |
All SZGR 2.0 genes in this pathway |
TARTE PLASMA CELL VS PLASMABLAST UP |
398 |
262 |
All SZGR 2.0 genes in this pathway |
NAKAJIMA EOSINOPHIL |
30 |
20 |
All SZGR 2.0 genes in this pathway |
LEI MYB TARGETS |
318 |
215 |
All SZGR 2.0 genes in this pathway |
RADMACHER AML PROGNOSIS |
78 |
52 |
All SZGR 2.0 genes in this pathway |
VERHAAK AML WITH NPM1 MUTATED DN |
246 |
180 |
All SZGR 2.0 genes in this pathway |
KANG FLUOROURACIL RESISTANCE DN |
16 |
10 |
All SZGR 2.0 genes in this pathway |
GAJATE RESPONSE TO TRABECTEDIN UP |
67 |
45 |
All SZGR 2.0 genes in this pathway |
SATO SILENCED EPIGENETICALLY IN PANCREATIC CANCER |
49 |
30 |
All SZGR 2.0 genes in this pathway |
JOSEPH RESPONSE TO SODIUM BUTYRATE UP |
31 |
21 |
All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 6HR UP |
953 |
554 |
All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP |
783 |
442 |
All SZGR 2.0 genes in this pathway |
CREIGHTON ENDOCRINE THERAPY RESISTANCE 3 |
720 |
440 |
All SZGR 2.0 genes in this pathway |
HELLER SILENCED BY METHYLATION UP |
282 |
183 |
All SZGR 2.0 genes in this pathway |
MASSARWEH TAMOXIFEN RESISTANCE UP |
578 |
341 |
All SZGR 2.0 genes in this pathway |
ENGELMANN CANCER PROGENITORS DN |
70 |
44 |
All SZGR 2.0 genes in this pathway |
SMID BREAST CANCER RELAPSE IN PLEURA DN |
27 |
15 |
All SZGR 2.0 genes in this pathway |
HUPER BREAST BASAL VS LUMINAL UP |
54 |
29 |
All SZGR 2.0 genes in this pathway |
CROMER TUMORIGENESIS DN |
51 |
29 |
All SZGR 2.0 genes in this pathway |
PARK APL PATHOGENESIS DN |
50 |
35 |
All SZGR 2.0 genes in this pathway |
HAN SATB1 TARGETS UP |
395 |
249 |
All SZGR 2.0 genes in this pathway |
HAN SATB1 TARGETS DN |
442 |
275 |
All SZGR 2.0 genes in this pathway |
POOLA INVASIVE BREAST CANCER UP |
288 |
168 |
All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN |
170 |
105 |
All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS PROLIFERATION UP |
178 |
108 |
All SZGR 2.0 genes in this pathway |
KOBAYASHI EGFR SIGNALING 24HR UP |
101 |
65 |
All SZGR 2.0 genes in this pathway |
HAHTOLA CTCL CUTANEOUS |
26 |
19 |
All SZGR 2.0 genes in this pathway |
HAHTOLA CTCL PATHOGENESIS |
16 |
9 |
All SZGR 2.0 genes in this pathway |
KYNG RESPONSE TO H2O2 VIA ERCC6 UP |
40 |
30 |
All SZGR 2.0 genes in this pathway |
HOFFMAN CLOCK TARGETS DN |
10 |
6 |
All SZGR 2.0 genes in this pathway |
DELPUECH FOXO3 TARGETS UP |
68 |
49 |
All SZGR 2.0 genes in this pathway |
GHANDHI DIRECT IRRADIATION DN |
33 |
23 |
All SZGR 2.0 genes in this pathway |
GHANDHI BYSTANDER IRRADIATION DN |
12 |
10 |
All SZGR 2.0 genes in this pathway |
NABA SECRETED FACTORS |
344 |
197 |
All SZGR 2.0 genes in this pathway |
NABA MATRISOME ASSOCIATED |
753 |
411 |
All SZGR 2.0 genes in this pathway |
NABA MATRISOME |
1028 |
559 |
All SZGR 2.0 genes in this pathway |